Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- RO.SW
- Price
- 257.60
- Stock movement down
- -0.40 (-0.15%)
- Company name
- Roche Holding AG
- Exchange
- (SW ,
- Currency
- CHF )
- Sector
- Healthcare >Drug Manufacturers - General
- Market cap
- 27.48B
- Ent value
- 85.57B
- Price/Sales
- 0.26
- Price/Book
- 0.84
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- 86.85%
- Trailing P/E
- 1.29
- Forward P/E
- 12.55
- PEG
- -
- EPS growth
- 3.21%
- 1 year return
- 7.15%
- 3 year return
- -15.90%
- 5 year return
- -3.66%
- 10 year return
- -0.42%
Last updated: 2025-04-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
RO.SW does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 1.29 |
| Price to OCF | 1.16 |
| Price to FCF | 1.56 |
| Price to EBITDA | 0.77 |
| EV to EBITDA | 2.40 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.26 |
| Price to Book | 0.84 |
| EV to Sales | 0.82 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 106.69M |
| EPS (TTM) | 26.52 |
| FCF per share (TTM) | 21.86 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 104.78B |
| Gross profit (TTM) | 77.68B |
| Operating income (TTM) | 32.52B |
| Net income (TTM) | 21.32B |
| EPS (TTM) | 26.52 |
| EPS (1y forward) | 20.52 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 74.14% |
| Operating margin (TTM) | 31.04% |
| Profit margin (TTM) | 20.35% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 4.82B |
| Net receivables | 12.17B |
| Total current assets | 33.63B |
| Goodwill | 10.99B |
| Intangible assets | 16.31B |
| Property, plant and equipment | 0.00 |
| Total assets | 95.79B |
| Accounts payable | 3.99B |
| Short/Current long term debt | 36.17B |
| Total current liabilities | 26.60B |
| Total liabilities | 62.91B |
| Shareholder's equity | 32.88B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 23.72B |
| Capital expenditures (TTM) | 6.14B |
| Free cash flow (TTM) | 17.58B |
| Dividends paid (TTM) | 15.27B |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 64.86% |
| Return on Assets | 22.26% |
| Return on Invested Capital | 54.82% |
| Cash Return on Invested Capital | 45.19% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 261.20 |
| Daily high | 264.40 |
| Daily low | 253.60 |
| Daily Volume | 40K |
| All-time high | 433.00 |
| 1y analyst estimate | 286.00 |
| Beta | 0.14 |
| EPS (TTM) | 26.52 |
| Dividend per share | - |
| Ex-div date | 27 Mar 2025 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| RO.SW | S&P500 | |
| Current price drop from All-time high | -40.51% | -12.89% |
| Highest price drop | -59.43% | -56.47% |
| Date of highest drop | 21 Sep 2001 | 9 Mar 2009 |
| Avg drop from high | -23.04% | -11.07% |
| Avg time to new high | 38 days | 12 days |
| Max time to new high | 3817 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
27.48B
Marketcap category
Large-cap
Description
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.
Employees
103605
Website
Investor relations
-
SEC filings
CEO
Country
Switzerland
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found